Review: Metformin does not increase risk for lactic acidosis in type 2 diabetes - Commentary

Annals of Internal Medicine

Volumn 153, Issue 2, 2010, Pages

  Tsapas, Apostolos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

DRUG SAFETY; HIGH RISK PATIENT; HUMAN; INCIDENCE; LACTIC ACIDOSIS; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL;

EID: 77957201853     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-2-201007200-02009     Document Type: Note

References (4)

1. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2009;52:17-30.
2. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-89.
3. Holstein A, Stumvoll M. Contraindications can damage your health - is metformin a case in point? Diabetologia. 2005;48:2454-9.
4. Bodmer M, Meier C, Krähenbühl S, Jick SS, Meier CR. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care. 2008;31:2086-91.